Results 171 to 180 of about 22,482 (226)

Intravitreal Anti-VEGF Injection Transitions Across Bevacizumab, Biosimilar, and Branded Medications: The IRIS Registry Study. [PDF]

J Vitreoretin Dis
Berkowitz ST, Gilbert JB, Ross CJ, Kearney WC, Lorch A, Miller JW, Rossin EJ, Sternberg P, Finn AP.   +8 more
europepmc   +1 more source

A Matching-Adjusted Comparison of Faricimab and Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.

Ophthalmic Res
Lim JI, Leng T, Siedlecki J, Lupidi M, Wells JA, Keane PA, Nudleman E, Mar F, Gibson K, Margaron P, Tabano D, Bührer C, Holekamp N.   +12 more
europepmc   +1 more source

Real-World Outcomes of Aflibercept 2 mg Using a Treat-and-Extend Protocol for Neovascular Age-Related Macular Degeneration: A 24-Month Retrospective Study in a Chinese Population. [PDF]

Drug Des Devel Ther
Qi Y, Cheng A, Xu J, Zhang C, Li S.
europepmc   +1 more source

Anti-vascular endothelial growth factors in retinal and choroidal diseases - Present landscape. [PDF]

Indian J Ophthalmol
Kannan NB, Vallinayagam M, Rishitha K, Ramasamy K.   +3 more
europepmc   +1 more source

A meta-analysis of clinical outcomes in diabetic macular edema. [PDF]

Adv Ophthalmol Pract Res
Bobrek CN, Kapoor I, Sarvepalli SM, Timtim E, Hadziahmetovic M.   +4 more
europepmc   +1 more source

Anti-vascular endothelial growth factor therapy for posterior segment diseases: Progress, challenges, and the road ahead. [PDF]

Indian J Ophthalmol
Mishra C, Mohanty N, Purohit S, Orugonda U, Patil V.   +4 more
europepmc   +1 more source

Error in Methods.

JAMA Ophthalmol
europepmc   +1 more source

Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration. [PDF]

Invest Ophthalmol Vis Sci
Shi J, Xu H, Zhao H, Zhao J, Chen L, Xu P, Jia D, Jiang C.   +7 more
europepmc   +1 more source

A novel Tie2xVEGF bispecific antibody fusion demonstrates enhanced therapeutic efficacy through direct Tie2 activation and VEGF neutralization. [PDF]

J Transl Med
Kwon MG, Kim SJ, Lee K, Song JH, Lee J, Kim I, Min JK, Kwon YG, Lee DG, Lee J, Lee NK.   +10 more
europepmc   +1 more source

The Evolving Role of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy: Evidence, Challenges, and Future Directions. [PDF]

Clin Ophthalmol
Li J, Wang Y, Wang W, Zhang X, Cui T, Zhou G.   +5 more
europepmc   +1 more source